• Interaction Score: 8.24

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Evidence Type Actionable
    Approval Status Preclinical
    Response Type resistant

    PMIDs:
    26597303


    Sources:
    JAX-CKB

  • Interaction Score: 0.92

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Lapatinib + Capecitabine
    Indication/Tumor Type breast cancer
    Response Type sensitive

    PMIDs:
    26487584


    Sources:
    JAX-CKB

  • Interaction Score: 0.71

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Erlotinib + Selumetinib
    Indication/Tumor Type pancreatic ductal adenocarcinoma
    Response Type sensitive

    PMIDs:
    26251290


    Sources:
    JAX-CKB

  • Interaction Score: 0.69

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Lapatinib + Capecitabine
    Indication/Tumor Type breast cancer
    Response Type sensitive

    PMIDs:
    26487584


    Sources:
    JAX-CKB

  • Interaction Score: 0.52

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Erlotinib + Selumetinib
    Indication/Tumor Type pancreatic ductal adenocarcinoma
    Response Type sensitive

    PMIDs:
    26251290


    Sources:
    JAX-CKB